Ischemic Heart Disease

  • Jim Nuovo
  • Amir Sweha


Cardiovascular disease remains the most significant cause of morbidity and mortality in the United States. In 1995 approximately 1.5 million Americans experienced a myocardial infarction (MI) and 700,000 of them died.1 It is estimated that 6.1 million Americans are alive today with a history of MI, angina, or both. The financial impact of this disease is enormous. The cost estimate for cardiovascular disease in 1995 was $110 billion. It is important for all primary care providers to implement screening and preventive care programs to reduce the burden of cardiovascular disease. Because of the high morbidity and mortality it is also important to recognize the early manifestations of this disease.


Depression Heparin Morphine Radionuclide Propranolol 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Deedwania PC. Clinical perspectives on primary and secondary prevention of coronary atherosclerosis. Med Clin North Am 1995;79:973–8.PubMedGoogle Scholar
  2. 2.
    Eisenberg MS, Cummings RO, Litwin PE, Hallstrom AP. Out-of hospital cardiac arrest: significance of symptoms in patients collapsing before and after arrival of paramedics. Am J Emerg Med 1986;4:116–20.PubMedCrossRefGoogle Scholar
  3. 3.
    Kuller L. Sudden death—definition and epidemiologic considerations. Prog Cardiovasc Dis 1980;23:1–12.CrossRefGoogle Scholar
  4. 4.
    Gordon T, Kannel WB. Premature mortality from coronary heart disease: the Framingham study. JAMA 1971;215: 1617–25.PubMedCrossRefGoogle Scholar
  5. 5.
    American Heart Association. Advanced cardiac life support in perspective. In: Textbook of advanced life support. Dallas: American Heart Association, 1987:1–10.Google Scholar
  6. 6.
    Fulp SR, Richter JE. Esophageal chest pain. Am Fam Physician 1989;40:101–16.PubMedGoogle Scholar
  7. 7.
    Klinkman MS, Stevens D, Gorenflo DW. Episodes of care for chest pain: a preliminary report from MIRNET. J Fam Pract 1994;38:345–52.PubMedGoogle Scholar
  8. 8.
    Kemp HG, Vokonas PS, Cohn PF, Gorlin R. The anginal syndrome associated with normal coronary arteriograms: report of a six-year experience. Am J Med 1973;54:735–42.PubMedCrossRefGoogle Scholar
  9. 9.
    Marchandise B, Bourrassa MG, Chairman BR, Lesperance J. Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis. Am J Cardiol 1978;41:216–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Proudfit WL, Bruschke AVG, Sones FM. Clinical course of patients with normal or slightly or moderately abnormal coronary arteriograms: 10-year follow-up of 521 patients. Circulation 1980;62:712–17.PubMedCrossRefGoogle Scholar
  11. 11.
    Day LJ, Sowton E. Clinical features and follow-up of patients with angina and normal coronary arteries. Lancet 1979;2:334–7.Google Scholar
  12. 12.
    Ockene IS, Shay MJ, Alpert JS, Weiner BH, Dalen JE. Unexplained chest pain in patients with normal coronary arteriograms: a follow-up study of functional status. N Engl J Med 1980;303:1249–52.PubMedCrossRefGoogle Scholar
  13. 13.
    Waxler EB, Kimbiris D, Dreifus LS. The fate of women with normal coronary arteriograms and chest pain resembling angina pectoris. Am J Cardiol 1971;28:25–32.PubMedCrossRefGoogle Scholar
  14. 14.
    Lavey EB, Winkle RA. Continuing disability of patients with chest pain and normal coronary arteriograms. J Chronic Dis 1979;32:191–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Isner JM, Salem DN, Banas JS, Levire HS. Long-term clinical course of patients with normal coronary arteriography: follow-up study of 121 patients with normal or nearly normal coronary arteriograms. Am Heart J 1981;102:645–53.PubMedCrossRefGoogle Scholar
  16. 16.
    Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986;7:479–83.PubMedCrossRefGoogle Scholar
  17. 17.
    DeMeester TR, O’Sullivan GC, Bermudez G, Midell Al, Cimochowiski GE, O’Drobinak JO. Esophageal function in patient with angina-type chest pain and normal coronary angiograms. Ann Surg 1982;196:488–98.CrossRefGoogle Scholar
  18. 18.
    Kline M, Chesne R, Studevant RL, McCallum RW. Esophageal disease in patients with angina-like chest pain. Am J Gastroenterol 1981;75:116–23.PubMedGoogle Scholar
  19. 19.
    Davies HA, Jones DB, Rhodes J. Esophageal angina as the cause of chest pain. JAMA 1982;248:2274–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Richter JE, Bradley LA, Castell DO. Esophageal chest pain current controversies in pathogenesis, diagnosis and therapy. Ann Intern Med 1989;110:66–78.PubMedCrossRefGoogle Scholar
  21. 21.
    Svensson O, Stenport G, Tibbling L, Wranne B. Oesophageal function and coronary angiogram in patients with disabling chest pain. Acta Med Scand 1978;204:173–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Schofield PM, Bennett DH, Whorwell 1J, et al. Exertional gastro-oesophageal reflux: a mechanism for symptoms in patient with angina pectoris and normal coronary angiograms. BMJ 1987;294:1459–61.PubMedCrossRefGoogle Scholar
  23. 23.
    Areskog M, Tibbling L, Wranne B. Noninfarction in coronary care unit patients. Acta Med Scand 1981;209:51–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Davies HA, Jones DB, Rhodes J, Newcombe RJ. Angina-like esophageal pain: differentiation from cardiac pain by history. Clin Gastroenterol 1985;7:477–81.CrossRefGoogle Scholar
  25. 25.
    Glade MJ. Continuous ambulatory esophageal pH monitoring in the evaluation of patients with gastrointestinal reflux: diagnostic and therapeutic technology assessment (DATTA) JAMA 1995;274:662–8.CrossRefGoogle Scholar
  26. 26.
    Pope CE. Chest pain: heart? gullet? both? neither? [editorial]. JAMA 1992;248:2315.Google Scholar
  27. 27.
    Clouse RE, Lustman PJ. Psychiatric illness and contraction abnormalities of the esophagus. N Engl J Med 1983;309: 1337–42.PubMedCrossRefGoogle Scholar
  28. 28.
    Katon W, Hall ML, Russo J, et al. Chest pain: relationship of psychiatric illness to coronary arteriographic results. Am J Med 1988;84:1–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Waxler EB, Kimbiris D, Dreifus LS. The fate of women with normal coronary arteries and chest pain resembling stable angina pectoris. Am J Cardiol 1971;28:25–32.PubMedCrossRefGoogle Scholar
  30. 30.
    Bass C, Wade C, Hand D, et al. Patients with angina with normal and near normal coronary arteries: clinical and psychosocial statistics 12 months after angiography. BMJ 1983; 287:1505–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Cannon RO, Quyyumi AA, Mincemoyer R, Stine AM, Gracely RH, Smith WB. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994;330:1411–17.PubMedCrossRefGoogle Scholar
  32. 32.
    Shub C. Stable angina pectoris. 1. Clinical patterns. Mayo Clin Proc 1990;65:233–42.PubMedCrossRefGoogle Scholar
  33. 33.
    Kemp HG. Left ventricular function in patients with the angina syndrome and normal coronary arteriograms [editorial]. Am J Cardiol 1973;32:375–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Kemp HG, Elliott WC, Gorlin R. The anginal syndrome with normal coronary arteriography. Trans Assoc Am Physicians 1967;80:59–70.PubMedGoogle Scholar
  35. 35.
    Cannon RO. Angina pectoris with normal coronary angiograms. Cardiol Clin 1991;9:157–66.PubMedGoogle Scholar
  36. 36.
    Colgan SM, Schofield PJ, Whorwell DH, Bennett DH, Brook NH, Jones PE. Angina-like chest pain: a joint medical and psychiatric investigation. Postgrad Med J 1988;64:743–6.PubMedCrossRefGoogle Scholar
  37. 37.
    Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Guidelines for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Procedures (Subcommittee on Exercise Testing). J Am Coll Cardiol 1986; 8:725–38.Google Scholar
  39. 39.
    Evans CH, Karunaratne HB. Exercise stress testing for the family physician. Part 1. Performing the test. Am Fam Physician 1992;45:121–32.PubMedGoogle Scholar
  40. 40.
    Evans CH, Karunaratne HB. Exercise stress testing for the family physician. Part 2. Am Fam Physician 1992;45:679–88.PubMedGoogle Scholar
  41. 41.
    Ellestad MH. Stress testing: principles and practice. 4d ed. Philadelphia: Davis, 1995.Google Scholar
  42. 42.
    Chaitman B. The changing role of the exercise electrocardiogram as a diagnostic and prognostic test for chronic ischemic heart disease. J Am Coll Cardiol 1986;8:1195–1210.PubMedCrossRefGoogle Scholar
  43. 43.
    Rivitz SM, Deluca SA. Perfusion imaging in ischemic heart disease. Am Fam Physician 1993;48:1071–8.PubMedGoogle Scholar
  44. 44.
    Botvinick EH. Stress imaging: current clinical options for the diagnosis, localization, and evaluation of coronary artery disease. Med Clin North Am 1995;79:1025–61.PubMedGoogle Scholar
  45. 45.
    Afridi I, Quinones MA, Zoghbi WA, Cheirif J. Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events. Am Heart J 1994;127: 1510–15.PubMedCrossRefGoogle Scholar
  46. 46.
    Beleslin BD, Ostojic M, Stepanovic J, et al. Stress echocardiography in the detection of myocardial ischemia: head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994;90:1168–76.PubMedCrossRefGoogle Scholar
  47. 47.
    Horwitz LD, Herman MV, Gorlin R. Clinical response to nitroglycerin as a diagnostic test for coronary artery disease. Am J Cardiol 1972;29:149–53.PubMedCrossRefGoogle Scholar
  48. 48.
    Frank CW, Weinblatt E, Shapiro S. Angina pectoris in men prognostic significance of selected medical factors. Circulation 1973;47:509–17.PubMedCrossRefGoogle Scholar
  49. 49.
    Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham study: prognosis and survival. Am J Cardiol 1972;29:154–63.PubMedCrossRefGoogle Scholar
  50. 50.
    Hilton TC, Chaitman BR. The prognosis in stable and unstable angina. Cardiol Clin 1991;9:27–39.PubMedGoogle Scholar
  51. 51.
    Holmes DR, Vliestra RE, Fisher LD, et al. Follow-up of patient from the Coronary Artery Surgery Study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty. Am Heart J 1983;106:981–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Hlatky MA, Califf RM, Kong Y. Natural history of patients with single-vessel disease suitable for percutaneous transluminal coronary angioplasty. Am J Cardiol 1983;52:225–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Pryor DB, Shaw L, Harrell FE, et al. Estimating the likelihood of severe coronary artery disease. Am J Med 1991;90: 553–62.PubMedGoogle Scholar
  54. 54.
    Mock MB, Rinquist I, Fisher LD, et al. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS registry). Circulation 1982;66:562–8.PubMedCrossRefGoogle Scholar
  55. 55.
    Goodman LS, Gilman A. The pharmacologic basis of therapeutics. 8th ed. New York: Macmillan, 1990:727–43.Google Scholar
  56. 56.
    Bomber JW, Detullio PL. Oral nitrate preparations: an update. Am Fam Physician 1995;52:2331–6.PubMedGoogle Scholar
  57. 57.
    Thadani U, Whitsett T, Hamilton SE. Nitrate therapy for myocardial ischemic syndromes: current perspectives including tolerance. Curr Probl Cardiol 1988;13:725–84.CrossRefGoogle Scholar
  58. 58.
    Thadani U, Davidson C, Singleton W, et al. Comparison of the immediate effects of five beta-adrenoceptor blocking drugs with different ancillary properties in angina pectoris. N Engl J Med 1979;300:750–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Braunwald E. Mechanism of action of calcium channel blocking agents. N Engl J Med 1982;307:1618–26.PubMedCrossRefGoogle Scholar
  60. 60.
    Opie LH. Calcium channel antagonists. Part II. Use and comparative properties of prototypical calcium antagonists in ischemic heart disease, including recommendations based on analysis of 45 trials. Rev Cardiovasc Drug Ther 1987;1: 4461–75.Google Scholar
  61. 61.
    Psaty BM, Heckbert ER, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:670–5.CrossRefGoogle Scholar
  62. 62.
    Thadani U. Medical therapy of stable angina pectoris. Cardiol Clin 1991;9:73–87.PubMedGoogle Scholar
  63. 63.
    Packer M. Drug therapy: combined beta-adrenergic and calcium entry blockade in angina pectoris. N Engl J Med 1989;320:709–18.PubMedCrossRefGoogle Scholar
  64. 64.
    Hennekens CH, Buring JE. Aspirin in the primary prevention of cardiovascular disease. Cardiol Clin 1994;12:443–50.PubMedGoogle Scholar
  65. 65.
    Manson JE, Grobbee DE, Stampfer MJ, et al. Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med 1990;89:772–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Shah PK. Pathophysiology of unstable angina. Cardiol Clin 1991;9:11–26.PubMedGoogle Scholar
  67. 67.
    Gottlieb SO, Weisfeldt ML, Ouyang P, et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986;314:1214–19.PubMedCrossRefGoogle Scholar
  68. 68.
    Nademanee K, Intarachot V, Josephson MA, et al. Prognostic significance of silent myocardial ischemia in patients with unstable angina. J Am Coll Cardiol 1987;10:1–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Braunwald E, Mark DB, Jones RH, et al. Diagnosing and managing unstable angina: quick reference guide for clinicians, Number 10. Rockville, MD: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research and National Heart, Lung, and Blood Institute, 1994. AHCPR Publication No. 94–0603.Google Scholar
  70. 70.
    Davies MJ, Thomas AC, Knapman PA, Hangartner JR. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986;73:418–27.PubMedCrossRefGoogle Scholar
  71. 71.
    Lewis HD, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration cooperative study. N Engl J Med 1983;309:396–403.PubMedCrossRefGoogle Scholar
  72. 72.
    National Center for Health Statistics. 1986 Summary: National Hospital Discharge Survey. Hyattsville, MD: NCHS, 1987. DHHS Publ. No. (PHS) 87–1250.Google Scholar
  73. 73.
    Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association task force on assessment of diagnostic and therapeutic cardiovascular procedures (subcommittee on percutaneous transluminal angioplasty). Circulation 1988;78:486–502.PubMedCrossRefGoogle Scholar
  74. 74.
    Faxon DR Percutaneouscoronary angioplasty in stable and unstable angina. Cardiol Clin 1991;9:99–113.PubMedGoogle Scholar
  75. 75.
    Sherman DL, Ryan TJ. Coronary angioplasty versus bypass grafting: cost-benefit considerations. Med Clin North Am 1995;79:1085–95.PubMedGoogle Scholar
  76. 76.
    Barsky AJ, Hochstrasser B, Coles A, et al. Silent myocardial ischemia: is the person or the event silent? JAMA 1990; 264:1132–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Droste C, Roskamm H. Experimental pain measurement in patients with asymptomatic myocardial ischemia. J Am Coll Cardiol 1983;1:940–5.PubMedCrossRefGoogle Scholar
  78. 78.
    Sheps DS, Light KC, Bragdon EE, et al. Relationship between chest pain, exercise endorphine response and depression. Circulation 1989;80 Suppl II:591–4.Google Scholar
  79. 79.
    Freeman LS, Nixon PGF, Sallabank P, et al. Psychologic stress and silent myocardial ischemia. Am Heart J 1987;114: 477–82.PubMedCrossRefGoogle Scholar
  80. 80.
    Rozanski A, Bairey CN, Krantz DS, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 1988;318:1005–12.PubMedCrossRefGoogle Scholar
  81. 81.
    Cohn PF. Silent myocardial ischemia. Ann Intern Med 1988; 109:312–17.PubMedCrossRefGoogle Scholar
  82. 82.
    Mody FV, Nademanee K, Intarachot V, et al. Severity of silent myocardial ischemia on ambulatory electrocardiographic monitoring in patients with stable angina pectoris: relation to prognostic determinants during exercise stress testing and coronary angiography. J Am Coll Cardiol 1988; 12:1169–96.PubMedCrossRefGoogle Scholar
  83. 83.
    Theroux P, Waters DD, Halphen C, et al. Prognostic value of exercise testing soon after myocardial infarction. N Engl J Med 1979;301:341–5.PubMedCrossRefGoogle Scholar
  84. 84.
    Gottlieb SO. Asymptomatic or silent myocardial ischemia in angina pectoris: pathophysiology and clinical implications. Cardiol Clin 1991;9:49–61.PubMedGoogle Scholar
  85. 85.
    Kinlen LJ. Incidence and presentation of myocardial infarction in an English community. Br Heart J 1973;35:616–22.PubMedCrossRefGoogle Scholar
  86. 86.
    Lavie CJ, Gersh BJ. Acute myocardial infarction: initial manifestations, management, and prognosis. Mayo Clin Proc 1990;65:531–48.PubMedCrossRefGoogle Scholar
  87. 87.
    Pathy MS. Clinical presentation of myocardial infarction in the elderly. Br Heart J 1967;29:190–9.PubMedCrossRefGoogle Scholar
  88. 88.
    Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham study. N Engl J Med 1984;311:1144–7.PubMedCrossRefGoogle Scholar
  89. 89.
    Marriott HJL. Practical electrocardiography. 6th ed. Baltimore: Williams & Wilkins, 1977:232–73.Google Scholar
  90. 90.
    Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction: recommendations based on a quantitative analysis. Ann Intern Med 1986;105:221–33.PubMedCrossRefGoogle Scholar
  91. 91.
    Guest TM, Jaffe AS. Rapid diagnosis of acute myocardial infarction. Cardiol Clin 1995;13:283–94.PubMedGoogle Scholar
  92. 92.
    Vasudevan G, Mercer DW, Varat MA. Lactic dehydrogenase isoenzyme determination in the diagnosis of acute myocardial infarction. Circulation 1978;57:1055–7.PubMedCrossRefGoogle Scholar
  93. 93.
    Gunnar RM, Lambrew CT, Abrams W, et al. Task force IV: pharmacologic interventions. Am J Cardiol 1982;50:393–408.PubMedCrossRefGoogle Scholar
  94. 94.
    Fillmore SJ, Shapiro M, Killip T. Arterial oxygen tension in acute myocardial infarction: serial analysis of clinical state and blood gas changes. Am Heart J 1970;79:620–9.PubMedCrossRefGoogle Scholar
  95. 95.
    ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2:349–60.Google Scholar
  96. 96.
    Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1:397–401.Google Scholar
  97. 97.
    GISSI-2 Investigators. GISSI-2: a factorial randomized trial of alteplase vs streptokinase and heparin vs no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65–71.Google Scholar
  98. 98.
    Lavie CJ, Gersh BJ, Chesebro JH. Reperfusion in acute myocardial infarction. Mayo Clin Proc 1990;65:549–64.PubMedCrossRefGoogle Scholar
  99. 99.
    Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two-year experience with 250 patients. Am T Cardiol 1967;20:457–61.CrossRefGoogle Scholar
  100. 100.
    Forrester JS, Diamond G, Chatterjee K, et al. Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 1976;295:1356–62.PubMedCrossRefGoogle Scholar
  101. 101.
    American Heart Association. Putting it all together. In: Textbook of advanced cardiac life support. Dallas: American Heart Association, 1987:235–48.Google Scholar
  102. 102.
    ACC / AHA Guidelines for the early management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction) . Circulation 1990; 82:664–707.Google Scholar
  103. 103.
    American College of Physicians. Evaluation of patients after recent acute myocardial infarction [position paper]. Ann Intern Med 1989;110:485–8.Google Scholar
  104. 104.
    Squires RW, Gau GT, Miller TD, Allison TG, Lavie CJ. Cardiovascular rehabilitation: status 1990. Mayo Clin Proc 1990; 65:731–55.PubMedCrossRefGoogle Scholar
  105. 105.
    O’Connor GT, Buring JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989;80:234–44.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Jim Nuovo
  • Amir Sweha

There are no affiliations available

Personalised recommendations